Applications published 14 October 2009

Pharmaceutical compsn comprising an camptothecin derivative
Sigma-Tau Industrie Farmaceutiche Riunite 2107903*

Compsns for the reversal and detoxification of anaesthetics and other compounds and methods of their use
Lyotrophic Therapeutics 2107904*

Solid preparation comprising alogliptin and pioglitazone
Takeda Pharmaceutical 2107905*

Novel therapeutic use for treating leukaemia
Sanofi-Aventis 2107906*

New combination for use in the treatment of inflammatory disorders
Cardoz 2107907*

Use of a TRMP5 inhibitor to regulate insulin and GLP-1 release
Redpoint Bio 2107908*

Compounds and pharmaceutical compsns for the treatment of liver disorders
Idenix Pharmaceuticals; Centre National de la Recherche Scientifique; L"Universite'Montpellier 2107909*

Polymer-drug conjugates with tether groups for controlled drug delivery
Insert Therapeutics 2107910*

Methods for determining cancer resistance to histone deacetylase inhibitors
Pharmaceyclics 2107911*

Ophthalmic and contact lens solutions containing forms of vitamin B
FXS Ventures 2107912*

• Use of polymers
Croma-Pharma Gesellschaft 2107913*

• Medical device capable of releasing NO
Arsenal Medical 2107914*

• Blood-containing medical devices for the release of nitric oxide and anti-restenotic agents
Boston Scientific Scimed 2107915*

• A gateway device
Unomedical 21067916*

• Method for the production of diphenylmethane diamine
BASF SE 2108011*

• Substituted N-(4-cyano-1H-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
Sanofi-Aventis 2108012*

• Crystalline forms of deferasirox
Teva Gyogyszergyar Zartkoeruen Mukoedo Resszenytarsasag 2108013*

• Method of preparing docataxel and intermediates used therein`
Hanmi Pharm 2108014*

• Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
Merck Frosst Canada 2108015*

• 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compsns and in particular IKK inhibitors
Sanofi-Aventis 2108016*

• Imidazole compounds as TGF-beta family type 1 receptors, alk5 and/or alk4 antagonists
Biogen Idec 2108018*

• 8-oxa-1,4-diazaspiro [4.5] dec-3-en-1-yl and 1,4,8-triazaspiro [4,5] dec-en-3-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
Glaxo Group; University of Nottingham 2108019*

• 1-H-pyrazolo[3,4-B]pyrimidine derivatives and their use as modulators of mitotic kinases
Biogen Idec 2108020*

• Aqueous formulations comprising acid groups and/or salts of acid group-carrying polyaromatic compounds, method for the production thereof, and use of the further formulations in fuel cells
BASF SE 2108021*